Pericarditis News and Research

RSS

Pericarditis is defined as the state of inflammation or infection of the pericardium, the membranous sac that encloses the heart. The cause and severity of pericarditis determines the type of treatment appropriate for this condition.

Study explores myopericarditis incidence and COVID-19 vaccination

Researchers investigated the impact of COVID-19 vaccination on the incidence of myopericarditis.

13 Apr 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022

Study shows third dose of Pfizer-BioNTech vaccine against COVID-19 is both safe and effective

A research paper published in the New England Journal of Medicine has demonstrated how a third dose of Pfizer-BioNTech (BNT162b2) vaccine administered in a median period of 10.8 months after the second one bestowed 95.3% efficacy against coronavirus disease 2019 (COVID-19), in comparison with two doses of the same vaccine during a median follow-up of 2.5 months.

24 Mar 2022

Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

A new study assesses whether the risk of myocarditis and pericarditis differs between the two mRNA vaccines.

23 Mar 2022

Incidence of myocarditis and pericarditis following COVID-19 vaccination

Researchers used a cohort design for the estimation of adjusted hazard ratios for hospitalized or fatal myocarditis/pericarditis following the first and second dose of BNT162b2 and ChAdOx1 vaccines.

10 Mar 2022

Myocarditis and pericarditis in COVID-19 vaccine recipients

A new study provides valuable evidence towards this end, using surveillance data to provide the best estimates of these outcomes.

6 Mar 2022

Case ascertainment of myocarditis following COVID-19 booster vaccine

Researchers from the US performed a time case surveillance of myopericarditis following COVID-19 booster vaccination in a cohort of health plan members of Kaiser Permanente Northwest Health System, Portland, Oregano.

17 Feb 2022

Cardiac MRI shows a similar injury pattern for vaccine-associated myocarditis

Vaccine-associated myocarditis shows a similar injury pattern on cardiac MRI compared to other causes of myocarditis, but abnormalities are less severe, according to a new study published in the journal Radiology.

15 Feb 2022

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Researchers estimated the risk and one-year burden of a set of pre-specified cardiovascular outcomes in a cohort of COVID-19-infected patients who survived the acute phase of illness.

9 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

In a new study, a team of researchers described the case of a healthy 49-year old male patient with new-onset atrial fibrillation after receiving the second dose of the COVID-19 mRNA-1273 (Moderna) vaccine.

19 Jan 2022

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

In a new study, a team of researchers estimated the pre-pandemic incidence rates of adverse events of special interest now observed in association with COVID-19 vaccines in Canada.

18 Jan 2022

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Researchers determine whether sequences within SARS-CoV-2 could lead to an immune response to autoantigens associated with autoimmune myocarditis.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

Pericarditis News and Research

Further Reading

Study explores myopericarditis incidence and COVID-19 vaccination

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Study shows third dose of Pfizer-BioNTech vaccine against COVID-19 is both safe and effective

Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

Incidence of myocarditis and pericarditis following COVID-19 vaccination

Myocarditis and pericarditis in COVID-19 vaccine recipients

Case ascertainment of myocarditis following COVID-19 booster vaccine

Cardiac MRI shows a similar injury pattern for vaccine-associated myocarditis

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Colchicine holds promise to reduce the risk of severe COVID-19

Impact of atrial fibrillation in COVID-19 vaccine-induced pericarditis patients

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Oral bacteria-based SARS-CoV-2 vaccine platform

Reviewing myocarditis and pericarditis in immunosuppressed individuals following COVID-19 mRNA vaccination

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News